As TRAIL alone does not completely eradicate tumoursphere-forming or tumour-initiating cells in any breast cancer cell line, we believe our data are evidence of heterogeneity existing in terms of susceptibility to TRAIL. Here, TNFSF10 is linked to neoplasm.